1-4 of 4
Manar Khalil
Close
Sort by
Journal Articles

Evaluation of Efficacy and Safety of Nivolumab in Treatment of Relapsed/Refractory Classical Hodgkin Lymphoma at King Abdulaziz Medical City-Jeddah/the Kingdom of Saudi Arabia Experience

Amani Reda Alsafi, Majed Alahmadi, Ahmed Absi, Ahmad S. Alsaeed, Sameer Alamoudi, Ihab Hemaidi, Walaa Rajkhan, Manar Khalil, Saleem Dadah, Ahmed Said Higazi, Mubarak Almansour, Roula Almufti
Journal: Blood
Blood (2023) 142 (Supplement 1): 6175.
https://doi.org/10.1182/blood-2023-190314
Published: 2023
Journal Articles

Brentuximab Vedotin Plus Bendamustine: As Salvage Regimen for Relapsed or Refractory Hodgkin Lymphoma, King Abdulaziz Medical City - Jeddah - KSA Experience

Muteb Althomali, Ahmad Absi, Ihab El Hemaidi, Ashraf Warsi, Sameer AlAmoudi, Majed Alahmadi, Walaa Rajkhan, Sultan Almutairi, Saleem Eldadah, Manar Khalil, Muna Adam, Syed Adnaan Ali, Abdulrahman Alghamdi, Ahmad Alsaeed
Journal: Blood
Blood (2019) 134 (Supplement_1): 5295.
https://doi.org/10.1182/blood-2019-121993
Published: 2019
Journal Articles

Parental Ferric Hydroxide Saccharate Therapy for Iron Deficiency Anemia: Safety and Efficacy.

Hikmat Abdel-Razeq, MD, Ghazala Radwi, MD, Manar Khalil, MD, Ali Bajouda, MD, Marifi Macalintal, RN
Journal: Blood
Blood (2004) 104 (11): 3681.
https://doi.org/10.1182/blood.V104.11.3681.3681
Published: 2004
Journal Articles

Renal Involvement in Saudi Patients with Sickle Cell Disease. A Single Institution Experience.

Hikmat N. Abdel-Razeq, MD, Ali Bajouda, MD, Manar Khalil, MD, Muneera Al-Shareef, MD, Nauman Siddiqi, MD
Journal: Blood
Blood (2004) 104 (11): 3734.
https://doi.org/10.1182/blood.V104.11.3734.3734
Published: 2004